Solventum Corporation (SOLV) financial statements and ratios from SEC XBRL: revenue $8.32B (TTM), net margin 18.7%, revenue growth -3.0% YoY, P/E 10.7. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $8.32B |
| Net Margin | 18.7% |
| Revenue Growth (YoY) | -3.0% |
| EPS Growth (YoY) | -91.1% |
| FCF Growth (YoY) | 241.3% |
| P/E Ratio | 10.7 |
| EV / EBITDA | 7.6 |
| Price / Book | 3.09 |
| Price / Sales | 1.86 |
| FCF Yield | -1.3% |
| DCF Value (model) | $138.40 |
| DCF Upside vs Price | 56.2% |
| Altman Z-Score | 2.32 (grey) |
| Sector P/E (Healthcare) | 21.6 |
SOLV overview · SOLV earnings · SOLV KPIs · SOLV investor relations · SOLV ownership · SOLV peers · SOLV filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.